XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Revenue $ 611,000 $ 956,000 $ 1,237,000 $ 1,994,000
Cost of revenues 491,000 834,000 1,120,000 1,596,000
Gross profit 120,000 122,000 117,000 398,000
Operating expenses:        
Research and development 65,000 5,000 115,000 11,000
Sales and marketing 57,000 (58,000) 111,000 160,000
General and administrative 1,016,000 1,577,000 2,093,000 2,746,000
Amortization 0 87,000 0 173,000
Impairment charges 0 2,000 0 2,000
Casualty gain (insurance proceeds) 0 (400,000) 0 (400,000)
Total operating expenses 1,138,000 1,213,000 2,319,000 2,692,000
Operating loss (1,018,000) (1,091,000) (2,202,000) (2,294,000)
Interest income, net (44,000) (42,000) (92,000) (64,000)
Loss before income taxes (974,000) (1,049,000) (2,110,000) (2,230,000)
Income tax expense 9,000 0 9,000 38,000
Net loss (983,000) (1,049,000) (2,119,000) (2,268,000)
Preferred stock dividends 20,000 149,000 64,000 149,000
Warrant modification 0 0 0 25,000
Induced conversion of warrants 0 751,000 0 751,000
Net loss attributable to common share holders $ (1,003,000) $ (1,949,000) $ (2,183,000) $ (3,193,000)
Net loss attributable to common stockholders per share:        
Basic and diluted net loss per share (in dollars per share) $ (0.04) $ (0.78) $ (0.11) $ (1.4)
Weighted-average number of shares of common stock:        
Basic and diluted (in shares) 22,882 2,487 20,003 2,277